Showing 151-155 of 155 results for "".
- Valeant Pharmaceuticals Appoints New Managementhttps://practicaldermatology.com/news/20130103-valeant_pharmaceuticals_appoints_new_management/2459649/Valeant Pharmaceuticals International, Inc. named Laizer D. Kornwasser the Executive Vice President/Company Group Chairman, where he will be responsible for operations in Canada, US Neurology, and managed care and distribution, effective February 1, 2013. Previously, Mr. Kornwasser was a Senior Exe…
- Patrick Burnett, MD, PhD, FAADhttps://practicaldermatology.com/profiles/patrick-burnett-md-phd-faad/OBAr9b/Patrick Burnett has served as Arcutis’ chief medical officer since August 2020. Prior to that, Dr Burnett was the chief medical officer at Verrica Pharmaceuticals since April 2018. Prior to that, Dr Burnett was at Sun Pharmaceuticals where he was associate vice president of clinical development fro…
Pain Relief for Next April 15th
https://practicaldermatology.com/topics/practice-management/pain-relief-for-next-april-15th--ivahevoh/18869/OJM Group Principal Carole Foos, CPA discusses strategies to help ease your individual and corporate tax burden for 2015 and years to come.To obtain a free copy of "Wealth Protection Planning for Dermatologists" visit the OJM Bookstore and enter the promo code DERMTUBE.To Be Shorr: Importance of Using Technology to Its Fullest Extent
https://practicaldermatology.com/topics/practice-management/to-be-shorr-importance-of-using-technology-to-its-fullest-extent/18605/Some of the administrative tasks that bog down a practice can be automated—and your existing vendors may have the applications and technology you need to make it happen. Be sure to investigate the services your vendors provide, many of which you already pay for, to make the most of your practice tecTaking the Patient-Centered Approach to Mycophenolate Risk Mitigation
https://practicaldermatology.com/programs/cme/taking-the-patient-centered-approach-to-mycophenolate-risk-mitigation-mycophenolate-risk-mitigation/16628/Explore this video roundtable featuring an interdisciplinary panel of experts discussing a woman’s journey with mycophenolate therapy and strategies to approach risk mitigation.
- Previous
- Next